Azenta (FRA:BA3) Growth Rank: 7 (As of Aug. 29, 2026) — 40% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:BA3 Azenta Inc FRA:BA3
78 GF Score
Price €28.40
GF Value €45.14
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Azenta Growth Rank?

Azenta FRA:BA3 -0.70% 78 Growth Rank is 7 as of Aug. 29, 2026, which is 40% above its 10-year median of 5.00. GuruFocus rates FRA:BA3 with a GF Score™ of 78/100 and a GF Value™ of €45.14 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Azenta has the Growth Rank of 7.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.


FRA:BA3 vs KMTS, STAA, BLFS: Growth Rank Comparison

For the Medical Instruments & Supplies subindustry, Azenta's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Azenta Growth Rank vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Azenta's Growth Rank distribution charts can be found below:

* The bar in red indicates where Azenta's Growth Rank falls into.


FRA:BA3
78GF Score
Azenta Inc FRA:BA3
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 7 mean?
Azenta (FRA:BA3) has a Growth Rank of 7 as of Aug. 29, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Azenta and its competitors. This is 40% above median its historical median of 5.00. Over the past decade, Azenta's Growth Rank has ranged from 1.00 to 10.00.
Is Azenta's Growth Rank too high?
Azenta's current Growth Rank of 7 is 40% above median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 10.00. Overall, Azenta has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Azenta's Growth Rank compare to KMTS and STAA?
Azenta's Growth Rank of 7 can be compared against companies in the Medical Devices & Instruments industry. Historically, Azenta's own Growth Rank has ranged from 1.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Medical Devices & Instruments company?
A good Growth Rank depends on the Medical Devices & Instruments industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Azenta and its competitors. Azenta's current Growth Rank is 7, which is 40% above median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Azenta stock overvalued right now?
Based on GuruFocus' analysis, Azenta (FRA:BA3) is currently considered Significantly Undervalued. The stock's GF Value™ is €45.14, compared to a current price of €28.40 — trading 37.1% below its estimated fair value. The current Growth Rank is 7, which is 40% above median its 10-year median of 5.00. Azenta's overall GF Score™ is 78/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Azenta (FRA:BA3), the current Growth Rank is 7 as of Aug. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Azenta (FRA:BA3) Overvalued in 2026?

Based on GuruFocus' analysis, Azenta stock appears to be undervalued. The current stock price of €28.40 is trading 37.1% below its estimated GF Value™ of €45.14. GuruFocus considers Azenta to be Significantly Undervalued.

Key valuation signals for FRA:BA3:

  • Growth Rank: 7 (40% above median its 10-year median of 5.00)
  • GF Value™: €45.14 vs. price of €28.40 (37.1% below fair value)
  • GF Score™: 78/100 with 1 warning sign

No single metric tells the full story. See the FRA:BA3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Azenta Business Description

Other Exchanges AZTA:USA0HQ1:UKBA3:Germany
Address 200 Summit Drive, 6th Floor, Burlington, MA, USA, 01803
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.
78GF Score

Get the complete analysis for FRA:BA3

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€28.40
Price
€45.14
GF Value